Central Venous Catheter Removal Versus In Situ Treatment in Neonates With Enterobacteriaceae Bacteremia
Autor: | Kellie J. Nazemi, Robert E. Kelly, M. Gary Karlowicz, E. Stephen Buescher |
---|---|
Rok vydání: | 2003 |
Předmět: |
Catheterization
Central Venous medicine.medical_specialty Neonatal intensive care unit medicine.medical_treatment Bacteremia Cohort Studies Enterobacteriaceae Intensive Care Units Neonatal Case fatality rate medicine Humans Expert Testimony Device Removal Retrospective Studies biology business.industry Enterobacteriaceae Infections Infant Newborn Retrospective cohort study equipment and supplies medicine.disease biology.organism_classification Confidence interval Anti-Bacterial Agents Surgery Aminoglycosides Treatment Outcome Relative risk Pediatrics Perinatology and Child Health Tobramycin Gentamicins business Central venous catheter |
Zdroj: | Pediatrics. 111:e269-e274 |
ISSN: | 1098-4275 0031-4005 |
DOI: | 10.1542/peds.111.3.e269 |
Popis: | Objective. To determine how often neonates with Enterobacteriaceae (ENTB) bacteremia can be treated successfully without removing central venous catheters (CVCs).Methods. A retrospective cohort study was conducted of ENTB bacteremia and CVCs in infants in a neonatal intensive care unit during a 7-year period (1994–2000). Cases of ENTB bacteremia were identified from a microbiology database and limited to late-onset cases occurring after 3 days of age.Results. There were 53 cases of ENTB bacteremia in infants with CVCs. Blood cultures were positive for ENTB within a median of 10 hours (range: 5–43). Timing of CVC removal was at the discretion of attending neonatologists. Fifteen cases had early-removal CVC (ER-CVC) within 2 days, and 38 cases had late-removal CVC (LR-CVC) >2 days after the first positive blood culture for ENTB. There were no significant differences between infants in the ER-CVC and LR-CVC groups for case fatality, recurrence, or duration of ENTB bacteremia. Although 16 (42%) of 38 (95% confidence interval [CI]: 26%–59%) LR-CVC cases required CVC removal to resolve ENTB bacteremia, 17 (45%) of 38 (95% CI: 29%–62%) LR-CVC cases were treated successfully without removal of CVCs. ENTB bacteremia was successfully treated without CVC removal in 85% of 13 LR-CVC cases with 1 day of bacteremia in contrast to 24% of 25 LR-CVC cases with >1 day of bacteremia (relative risk: 3.5; 95% CI: 1.7–7.4). CVC removal was required to resolve ENTB bacteremia in 9 (82%) of 11 LR-CVC cases with severe thrombocytopenia compared with 7 (32%) of 22 LR-CVC cases without severe thrombocytopenia (relative risk: 2.6; 95% CI: 1.3–5.0).Conclusions. Retention of CVCs was successful in 45% of cases of ENTB bacteremia in which it was attempted, but success was unlikely when bacteremia lasted >1 day. ENTB bacteremia cases associated with severe thrombocytopenia rarely resolved unless CVCs were removed. |
Databáze: | OpenAIRE |
Externí odkaz: |